4,000 HIV infected infants die yearly
SEE ALSO :Footballer’s home vandalised following penalty miss
This is despite the report indicating that 100 per cent of the specimens taken from the infants is delivered to health practitioners attending to the infants. The UNAids report notes that in developing countries virological testing technologies are often only available in centralised reference laboratories. The report recommends considerate infrastructure and training as well as good transport networks for the delivery of specimens to laboratories. “The process of transporting samples to central laboratories, batching blood samples for testing to cetralised labs and returning the results to testing sites creates long delays between the time blood sample is collected and when result is received,” it reads. Unfortunately, as the November report notes, the said constraints are not limited to remote areas.SEE ALSO :Knowing your status is the first step in addressing HIV
Even in urban areas close to laboratories, turnaround times can stretch three to four months. This is past the time period of peak mortality — and the proportion of results returned can be as low as one in five. “The result is a delay in initiating treatment — or a complete failure to initiate it — and high levels of infant mortality,” the report warns. “High rates of HIV drug resistance have been observed in infants, children and adolescents.” The genesis of this challenge, as UNAids indicated, cannot be solely blamed on countries' inefficiencies in their programmes. For long, linking children to treatment following HIV infection and diagnosis has been challenging. “HIV treatment services are usually designed for adults and tend to lack consideration of the specific needs of younger people (children and adolescents),” the report says.
